You are not logged in.

Supply of Supplements for Inherited Metabolic Disease

Details

RFx ID : 31010801
Tender Name : Supply of Supplements for Inherited Metabolic Disease
Reference # : A1866646
Open Date : Q1 2025
Indicative RFx Release Date  : Q1 2025  [?]
Tender Type : Future Procurement Opportunity (FPO)
Project Status : Initial development  [?]
Indicative Total Value : $250K - $500K  [?]
Expected number of contracts offered : 3
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Required Pre-qualifications : None
Contact : Pharmac Procurement Team
procurement@Pharmac.govt.nz
Overview

Pharmac is planning to issue a Registration of Interest (ROI) for the supply of supplements for inherited metabolic disease to be funded in the community and in Health NZ hospitals.

This planned ROI follows Pharmac’s recent expansion of the range of funded supplements for people with inherited metabolic diseases and intends to consider supplements for inherited metabolic disease not currently funded in New Zealand.

Any supplements contracted for through the planned ROI or any subsequent procurement activity would be listed on the Pharmaceutical Schedule alongside currently available supplements for inherited metabolic disease.

All currently funded supplements for inherited metabolic disease would not change as a result of this process and would continue to be fully funded.

Details of the currently funded supplements for inherited metabolic disease are available here.

https://schedule.pharmac.govt.nz/ScheduleOnline.php?code=A4212

For the avoidance of doubt the scope of the planned ROI and any subsequent procurement activity would be limited to supplements in powder, liquid or tablet formulations and would not include foods for people with inherited metabolic diseases.